Skip to main content
Premium Trial:

Request an Annual Quote

GenUS BioSystems, Expression Profiling Provider, Hatches from Incubator

NEW YORK, Sept. 1 (GenomeWeb News) - GenUs BioSystems, a provider of gene expression-profiling services, has moved from the Chicago Technology Park's Research Center, a biotechnology incubator, to larger premises, the Illinois Medical District Commission said yesterday.

 

GenUs, founded in 2003, is now located in Northbrook, Ill., where the company acquired 2,400 square feet of lab and office space.

 

The company's move was prompted by the addition of new technologies and services and by the continued growth of its customer base, according to IMDC.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.